Find out more about our subscription products and services by visiting our websites: CorporateHealthcareEnergy
Report Store

Search Within Market Intelligence

Keywords:
Search In
Industry:
Pub Month: From  To 
Price Range ($): Min       Max
 
 
 
 
Free Research Alert
Sign up for updates on the latest research
Email: 
 
 
Call us now on +44 1204 543 529
to speak to an advisor
 

PharmaLeaders: CRO Benchmark Report – Financial Benchmarking & Competitive Landscape Assessment of Leading CROs

Published: Aug-2013    Report Format:
Report Code: GDHC002PLR
Pharmaceuticals and Healthcare
Single User License
Single User License
$3995
Site License
Site License
$7990
Global License
Global License
$11985
The CRO Benchmark Report applies GlobalData’s proprietary ranking methodology to compare the competitive positions of 11 leading CRO companies on 17 financial metrics. These companies are analyzed based on financial performance, cost-containment, capital structure and firm utilization to illustrate the different strategies these companies are using to increase value for their shareholders. Throughout the report, GlobalData’s Industry Dynamics Team provides you with expert insight, expanding on each of the metrics discussed. In addition to the financial metrics, this report discusses trends impacting the CRO marketplace, along with partnering and acquisition activity, and operations strategy. This report also provides drill-down analyses of three service lines and four geographies examining each of these segment’s revenue and growth leaders, and business development strategies. Lastly, this report provides GlobalData’s outlook on the CRO sector and each company’s future competitive position.

Scope

  • Analysis of the key drivers and trends shaping the global CRO market; including biologics manufacturing, emerging markets, and eClinical technologies
  • A deep dive into the synergies behind partnering and acquisition activity
  • Discussion of business line and regional segment strategies
  • Assessments of company financials by revenue, margin, expense and capital structure
  • Firm utilization, resources management, and efficiency metrics
  • Leadership/management changes

Reasons To Buy

  • Analyze and track the strategies that these CROs are using to gain share in the increasingly competitive market
  • Understand the underlying financial metrics that differentiate certain companies from the pack in terms of growth and profitability, spending and asset structure
  • Organize your sales and marketing strategy to identify companies with proprietary technologies to maximize opportunities for strategic investment or partnerships
  • Use this information as an independent source for your due diligence and transaction strategy

About The Report

The CRO market is highly fragmented comprised of some 1,000 individual companies, most of which are privately owned. These companies vary significantly in size and breadth of services – from a four person bioanalysis research lab in Thailand to companies like Quintiles and Covance which have tens of thousands of employees in over 100 countries across the globe. GlobalData identified 11 CROs to apply its benchmarking methodology providing a foundation for strategic discussion and analysis. GlobalData’s coverage examines these CROs from a unique company-centric lens – combining financial performance and resources allocation with partnering activity and regional developments to assess a company’s overall strategy. This type of coverage is unlike any other analysis available, and delivers a consistent view into the evolution of these companies corporate growth. We also covered some 30 other privately-held CROs to give our analysis more specificity and granularity.

Request Sample Pages

First Name*:
Last Name*:
Company / Organization*:
Email Address*:
Country*:
Phone Number*:  
Time Zone:
Comments:
 
 
 

Report at a Glance

  • Pages: 126
  • Number of Tables: 10
  • Number of Figures: 50
  • Companies Covered: 40
 
 
© GlobalData 2014. John Carpenter House, 7 Carmelite Street, London EC4 O85.